Cargando...
How We Treat Febrile Neutropenia in Patients Receiving Cancer Chemotherapy
Although improved supportive care has reduced mortality associated with febrile neutropenia, it continues to cause chemotherapy limitations, morbidity, mortality, and cost among patients with cancer.
Gardado en:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
American Society of Clinical Oncology
2010
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2868641/ https://ncbi.nlm.nih.gov/pubmed/20808559 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JOP.091092 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|